Results 131 to 140 of about 274,618 (211)

Leptomeningeal Metastasis in Non-Small-Cell Lung Cancer with Actionable Genomic Alterations: Pathogenesis, Diagnosis, and Emerging Therapeutic Strategies. [PDF]

Cancers (Basel)
Lim SW, Ku BM, Ahn MJ.
europepmc   +1 more source

Intrathecal Allogeneic B7-H3-Targeted CAR γδ T Cells for Leptomeningeal Metastasis from Solid Tumors: Safety, Efficacy, and Immunologic Dynamics in a Phase I Trial. [PDF]

Clin Cancer Res
Ma P, Zhou Y, Ma W, Wang Y, Cai H, Sui Y, Zhao L, Zhang Y, Wang S, Li N.   +9 more
europepmc   +1 more source

Advances in Ommaya reservoir-based intrathecal therapy for leptomeningeal metastasis from non-small cell lung cancer: a systematic review. [PDF]

Front Oncol
Jiang C, Zhao Y, Chen D, Yuan X.
europepmc   +1 more source

Medulloblastoma with leptomeningeal metastasis

, 2019
openaire   +1 more source

Clinical outcomes of intrathecal anti-PD-1 therapy with or without whole-brain radiotherapy in melanoma leptomeningeal metastasis: a multicenter retrospective study. [PDF]

Front Immunol
Zhen J, Zhang R, Li D, Ding Y, Wen X, Yang Y, Wang H, Lai M, Zhang X, Cai L, Li J.   +10 more
europepmc   +1 more source

Proton Craniospinal Irradiation for Patients With Leptomeningeal Metastasis: A Randomized Clinical Trial. [PDF]

JAMA Oncol
Yang JT, Yerramilli D, Pentsova E, Wolden S, Young RJ, Correa DD, Imber BS, Wijetunga NA, Goglia AG, Zhang Z, Zheng J, Baser R, Bernstein A, Kratochvil L, Xiao J, Hattangadi-Gluth J, Miller AM, Wilcox JA, Betof Warner A, Yu H, Kris MG, Seidman AD, Powell SN, Boire A.   +23 more
europepmc   +1 more source

Prognostic value of Neutrophil-to-Lymphocyte Ratio (NLR) in patients with Leptomeningeal Metastasis (LM) from solid tumors. [PDF]

BMC Cancer
Tong N, Qu Y, Guo K, Li M, Chen H, Sun L, Sun C, Xia L.   +7 more
europepmc   +1 more source